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In this issue of Cell Stem Cell, Pan et al. (2007) and Zhao et al. (2007) report genome-wide histone
H3 trimethylations at lysines 4 and 27 in human embryonic stem (ES) cells. Similar gene sets arise
via different experimental systems, advancing our understanding of stem cell epigenetics.Trimethylation of histone H3 lysine 4
(H3K4me3) is generally associated
with the active state of chromatin,
whereas trimethylation of histone ly-
sine 27 (H3K27me3) correlates with
the repressive state of chromatin.
Recently the colocalization of these
opposing histone modifications was
discovered in mouse embryonic stem
(ES) cells by analyzing 2.5% of the
mouse genome (Bernstein et al.,
2006) and a handful of genes (Azuara
et al., 2006). This pattern, dubbed as
a ‘‘bivalent domain,’’ is observed in
clusters of homeobox genes and other
genes related to early embryonic de-
velopment, which are generally tran-
scribed at low level in undifferenti-
ated ES cells. Polycomb genes (e.g.,
SUZ12) are shown to be important for
maintenance of these temporarily re-
pressed chromatin regions (Cao and
Zhang, 2004; Lee et al., 2006). The bi-
valent domains are proposed to mark
genes that are silent but poised to be
activated (Azuara et al., 2006; Bern-
stein et al., 2006). Furthermore, these
studies indicated that bivalent do-
mains might be unique to ES cells
and thus would provide a possible
mechanism for the hallmark properties
of pluripotency and epigenetic plastic-
ity specific to ES cells (Azuara et al.,
2006; Bernstein et al., 2006). The latest
whole-genome analyses of H3K4me3
and H3K27me3 in mouse ES cells
(Mikkelsen et al., 2007) and human
ES cells (Pan et al., 2007 and Zhao
et al., 2007, in this issue of Cell Stem
Cell) confirm the previous findings by
identifying several thousand genes
marked with both H3K4me3 and
H3K27me3 in ES cells, but also implythat bivalent domains are not a unique
property of ES cells.
Three studies use different ES cell
lines for the genome-wide chromatin
immunoprecipitation (ChIP) to capture
DNA fragments associated with dif-
ferent histone H3 methylation marks,
followed by either hybridization to
whole-genome microarrays (Pan et al.,
2007), sequencing of concatenated
DNA ditags (Zhao et al., 2007), or
single-molecule-based sequencing
(SMS) (Mikkelsen et al., 2007). Despite
the varied experimental approaches,
these papers show remarkable consis-
tency in the lists of genes with differ-
ent combinations ofmethylationmarks:
both H3K4me3 and H3K27me3 (Fig-
ure 1A), H3K4me3 only (Figure 1B),
and neither H3K4me3 nor H3K27me3
(Figure 1C). For example, Zhao et al.
found 1798 genes with both H3K4me3
and H3K27me3 marks in their pro-
moters, 78% of which overlap with
data from Pan et al. (Figure 1A). Simi-
larly, out of 3301 genes with both
H3K4me3 and H3K27me3 marks iden-
tified by Pan et al., 42% match with
data fromZhaoetal. Theslightly smaller
overlapping fraction may be due to the
use of more relaxed statistical criteria.
Lists of genes with H3K4me3 alone
have a large overlap between all three
studies: 6409 genes were identified in
all three papers, and 9864 genes were
identified in at least two papers (Fig-
ure 1B). Yet another study of H3K4me3
in human ES cells also reported highly
consistent results (Guenther et al.,
2007): 92% of H3K4me3 regions identi-
fiedbyZhaoetal. (2007) overlapwith re-
gions found by Guenther et al. (2007).
Genes marked with neither H3K4me3Cell Stem Cell 1,nor H3K27me3 also show significant
overlap between the two studies of
human ES cells, although the intersec-
tion of human and mouse gene sets is
smaller (Figure 1C). This high degree of
consistency among the studies using
different ES cell lines and methods indi-
cate that these data are reliable, espe-
cially for common genes such as a set
of 2157 (12% of 18,000 analyzed
genes) with bivalent domains on their
promoters identified by at least two
independent studies.
Are these bivalent domains indeed
unique to pluripotent cells, as originally
proposed? These new studies show
that genes associated with bivalent
domains can also be found in mouse
neural progenitor cells (NPCs) and em-
bryonic fibroblasts (MEFs) (Mikkelsen
et al., 2007) and in a diploid human
lung fibroblast cell line (IMR90) (Pan
et al., 2007). Similarly, previous work
identified bivalent domains in human
T cells (Barski et al., 2007; Roh et al.,
2006). Therefore, while pluripotent
cells exhibit consistent colocalization
of H3K4me3 with H3K27me3, bivalent
domains seem to be functional in more
differentiated cells, as well.
The original identification of bivalent
domains in ES cells was a landmark
finding, given that colocalization of
activating H3K4me3 with repressing
H3K27me3 on the same regions was
highly unexpected (Azuara et al.,
2006; Bernstein et al., 2006). However,
the two present studies using human
ES cells reveal consistently that very
few genes exhibit H3K27me3 alone,
and even fewer of those genes overlap
between studies (only seven genes
between [Pan et al., 2007; Zhao et al.,September 2007 ª2007 Elsevier Inc. 237
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Previews2007]). H3K27me3 is almost always
accompanied by at least weak
H3K4me3 that may not always be de-
tectable using fixed statistical thresh-
olds (Pan et al., 2007; Zhao et al.,
2007). This suggests that bivalent do-
mains may not be an unusual feature
but instead represent the typical pat-
ternwhen repressiveH3K27me3marks
are present.
Another model proposed based on
the original studies is that bivalent do-
mains are associated with develop-
mental or lineage-specific genes that
are required to be silent in undifferenti-
ated ES cells but must be quickly acti-
vated during ES cell differentiation,
i.e., ‘‘primed’’ (Azuara et al., 2006) or
‘‘poised’’ (Bernstein et al., 2006). Pan
et al. modify this notion by presenting
the following observations: (1) pluri-
potency genes, such as POU5F1,
NANOG, and SOX2, are marked by
H3K4me3 alone and only acquire
bivalent marks during differentiation.
At this stage in development, these
genes are not considered tobe in a cat-
egory of requiring quick activation. (2)
Many genes marked by H3K4me3
only, or by neither H3K4me3 nor
H3K27me3, are also activated quickly
during retinoic acid-induced differenti-
ation of ES cells (Pan et al., 2007).
Taken together, these new studies
provide convincing lines of evidence
that bivalent domains are not uniquely
a feature of ES cells, and do not
provide a simple, albeit attractive, ex-
planation for ES cell epigenetic plastic-
ity and pluripotency. Further studies
will be required to assess whether bi-
valent domains indeed play a specific
role related to pluripotency in ES cells.
In summary, mapping chromatin
modifications across the genome of
human and mouse is a significant first
step toward understanding the mech-
anisms of gene expression regulation
in pluripotent stem cells. Because
only a handful of data sets for these
genome-wide marks are available,
these data provide a valuable resource
not only to stem cell biologists but also
to researchers generally interested in
gene expression regulation. As usual
for genome-wide studies, the amount
of information provided in these
papers is vast and demands greater
Figure 1. Venn Diagram Showing the Overlap among Genes
Venn diagram showing the overlap among genes identified by Pan et al. (2007) on human H1 ES
cells, Zhao et al. (2007) on human hES3 ES cells, and Mikkelsen et al. (2007) on mouse V6.5 ES
cells. Common genes were identified by comparing nonredundant gene symbols in each list
provided as supplemental tables. Human and mouse gene symbols were compared using the
HomoloGene database (release 57) at the National Center for Biotechnology Information
(NCBI). (A) Genes marked by both H3K4me3 and H3K27me3. (B) Genes marked by H3K4me3
only. (C) Genes marked by neither H3K4me3 nor H3K27me3. A list of combined genes is available
with this article as an online supplement (Table S1).238 Cell Stem Cell 1, September 2007 ª2007 Elsevier Inc.efforts from readers. However, those
who make the effort will be rewarded
with an incredibly rich source of infor-
mation, just waiting to be mined by
the research community.
Supplemental Data
Supplemental Data include one table and can
be found with this article online at http://www.
cellstemcell.com/cgi/content/full/1/3/237/DC1/.
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